APA (7th ed.) Citation

Frankel, A. E., Coughlin, L. A., Kim, J., Froehlich, T. W., Xie, Y., Frenkel, E. P., & Koh, A. Y. (2017). Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients. Neoplasia (New York, N.Y.), 19(10), 848-855. https://doi.org/10.1016/j.neo.2017.08.004

Chicago Style (17th ed.) Citation

Frankel, Arthur E., Laura A. Coughlin, Jiwoong Kim, Thomas W. Froehlich, Yang Xie, Eugene P. Frenkel, and Andrew Y. Koh. "Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients." Neoplasia (New York, N.Y.) 19, no. 10 (2017): 848-855. https://doi.org/10.1016/j.neo.2017.08.004.

MLA (9th ed.) Citation

Frankel, Arthur E., et al. "Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients." Neoplasia (New York, N.Y.), vol. 19, no. 10, 2017, pp. 848-855, https://doi.org/10.1016/j.neo.2017.08.004.